Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Neopath

This article was originally published in The Gray Sheet

Executive Summary

Neopath: Investigating complementing its AutoPap 300 automated Pap smear analyzer system with Cambridge, Massachusetts-based CompuCyte Corporation's Pathfinder cytology system, which it has purchased for $5 mil. in cash and stock. The Pathfinder, which consists of a microprocessor-controlled microscope capable of recording data on screened areas, will continue to be sold as a stand-alone product while NeoPath investigates using it to "guide the cytotechnologist to suspicious cells identified by the AutoPap," the firm says in a release...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel